Researchers at Emory University School of Medicine have identified hepcidin, a hormone that regulates iron levels in the body, as a potential target for treating atherosclerosis.
- Groups
-
Parker H. Petit Institute for Bioengineering and Bioscience (IBB)
- Categories
-
No categories were selected.
- Keywords
-
Hormone That Controls Iron Levels May Be Target for Atherosclerosis Treatment
- Status
-
- Created By: Colly Mitchell
- Workflow Status: Published
- Created On: Dec 1, 2011 - 6:04am
- Last Updated: Oct 7, 2016 - 10:25pm
